Posted by David Fay, on 20 May 2026
From the helpimascientist.com archive, an in-depth discussion covering the many purposes of laboratory group meetings and why you should care about all of them.
(No Ratings Yet)
Loading...
Posted by Ruben Marin-Juez, on 20 May 2026
Closing Date: 31 August 2026
Position Overview:
Research laboratory presentation
The Marín-Juez laboratory, at the CHU Sainte-Justine Research Center, is recruiting PhD students and postdoctoral fellows (up to 5 years fully funded position). Our laboratory is interested in the cellular and molecular mechanisms regulating cardiac regeneration and development.
The successful applicant will join the Marín-Juez laboratory at the CHU Sainte-Justine Research Center, where they will have access to state-of-the-art facilities and technology platforms including Advanced imaging platform (light-sheet, spinning-disc confocal, multiphoton, STED super-resolution, etc.), genomics (DropSeq, 10x, Illumina Novaseq, Visium), IPSC Cell Reprograming and bioinformatics platforms. The CHU Sainte-Justine Research Center provides a thriving scientific environment where the successful applicant will have the opportunity to work with multidisciplinary scientific teams and to collaborate with talented clinicians and researchers.
Research project description
We have previously uncovered mechanisms governing coronary network replenishment, including the formation of a vascular scaffold that supports cardiomyocyte regeneration and mediates coronary-epicardial interactions and immune responses (Marín-Juez et al., PNAS 2016; Marín-Juez et al., Dev Cell 2019; El-Sammak et al., Circ Res 2022; Wang et al., Development 2024; Gupta et al. Dev Bio 2025; Rouf et al. Development 2026). Our recent work identifies the epicardium as a master regulator of cardiac fibrosis resolution and tissue replenishment (Kayman-Kürekçi et al. NCVR2026).
Building on these findings, we now aim to elucidate how the cardiac endothelium, epicardium, and immune system components cooperate to regulate tissue replenishment, as well as the specific mechanisms underlying their roles in cardiomyocyte regeneration and development.
PhD student position
Applicants should have training in molecular biology, cell biology, or related fields. Candidates should be enthusiastic about regenerative and developmental biology. Previous research experience with zebrafish and/or heart regeneration is highly valued but not essential. Candidates with experience in confocal/light-sheet imaging and/or genome engineering are strongly encouraged to apply.
Postdoc position
We are looking for candidates with a Ph.D. in the biological sciences and laboratory experience in tissue repair/regeneration, cellular, molecular biology, or genetics. Previous experience working with zebrafish, imaging and histology are highly valued but not essential. Candidates with experience in confocal/light-sheet imaging and/or genome engineering are strongly encouraged to apply. Preference will be given to applicants with excellent collaborative and communication skills.
How to apply
Candidates must send the required documentsto Rubén Marín Juez at ruben.marin.juez.hsj@ssss.gouv.qc.ca
Please provide:
(No Ratings Yet)Loading...
Posted by Sergio Ruiz, on 18 May 2026
The Ruiz lab is offering fully funded postdoctoral positions up to five years in the Laboratory of Genome Integrity located at the National Institutes of Health (NIH, Bethesda, MD). NIH is the largest biomedical research agency in the world, fosters world-renowned researchers and provides access to state-of-the art innovative technologies and scientific resources.
Our laboratory uses human and mouse embryonic stem cells (ESCs) as well as mouse embryos to understand the molecular mechanisms underlying cell fate decisions. The applicant should have or be about to have a PhD in Developmental Biology, Genetics, Molecular Biology or similar, and must have demonstrated expertise in mouse early embryology (mouse pre-implantation embryo isolation and in vitro mouse embryo culture). Expertise in embryo microinjection and manipulation will be considered an advantage. In addition, molecular biology/mammalian cell culture (preferably in embryonic stem cells) and knowledge of next generation sequencing technologies will also be relevant for the position.
The applicant will be involved in a variety of exciting projects studying cell plasticity/totipotency to explore the underlying mechanisms of new regulators of Zygotic Genome Activation. We seek highly motivated, creative individuals, eager to learn and develop new technologies and complex cell systems based on live cell/embryo imaging, single-cell technologies and CRISPR-based editing, interested in understanding how a single cell can develop into a complex multicellular organism in vitro and in vivo.
Please send a brief cover letter and the names of three references via e-mail to:
Email: sergio.ruizmacias@nih.gov
Laboratory web: https://ccr.cancer.gov/Laboratory-of-Genome-Integrity/sergio-ruiz-macias
Recent publications from the lab:
(No Ratings Yet)Loading...
Posted by Saanjbati Adhikari, on 14 May 2026
So, recently I attended a developmental biology conference – my first one of 2026, with six more to go! While socialising and networking with a group of truly amazing stem cell researchers, many of them asked, after I introduced myself as a Reviews Editor at Development, “What exactly does a Reviews Editor do?” After answering this question at least five times – across scientists at different career and life stages – I realised it might be time to share with you all what we ‘cool kids’ actually do.
Normally, at The Company of Biologists (Development’s publisher), we follow a hybrid working model, which means that we work from home for half of the week (which is usually 2-3 days a week for me) and the rest in the office. If you haven’t seen a photo of our office building yet, it is a rather beautiful building, combining the charm of a cottage-style exterior (complete with hipped roofs and classic sash windows) with a bright, modern and open-style office inside.
At Development, Ingrid Tsang and I are the Reviews Editors and we mainly handle the journal’s front-section content (so, that includes Reviews, Spotlights, Perspectives, Hypotheses, Primers, interviews – yeah, we have an extensive list!) and we work closely with Alex Eve, Executive Editor of Development.
I normally start my workday between 9:30-10 am, and my first task is always to reply to emails while sipping my morning coffee (a strong flat white if I am home and a long cappuccino when in the office).
After the first half an hour to attending to emails regarding submissions, chasing authors for their submissions, or finishing off a pending task from the previous day (which often involves taking a final read through a decision letter), I move on to the main tasks of the day.
If I am working on a chunky edit – meaning a developmental edit of a Review article – I would usually block off an entire day for it (at least 7–8 hours). This typically happens once a Review-type article (which we commission in-house and invite authors to submit) has gone through peer review. At that stage, we, the in-house Reviews Editors, read through the full manuscript in detail, commenting on scientific accuracy, language and structure, conciseness and accessibility, journal style, article length and references – all while helping authors address the Reviewers’ comments more effectively. I also go through the figures and legends (we take our display items very seriously, as a single figure often speaks a thousand words), commenting on visual appeal, labelling and other finer details. Developmentally editing an article is usually the most rigorous part of the job, at least in my opinion, as it ensures that the final piece is not only of high quality but also forward-looking and engaging for our wide readership. At Development, we pride ourselves on being extremely hands-on when guiding authors and helping them address both our feedback and the Reviewers’ comments, in order to publish the best possible version of their review.
Another crucial part of our job is commissioning. We have our in-house commissioning meetings every two weeks. So, if you catch me the afternoon before, I am usually frantically reading articles on a certain topic of interest, trying to prepare somewhat cohesive pitches to discuss with the rest of the team. We mainly invite authors to write peer-reviewed, review-type content for us. To identify emerging topics in the field, we attend important conferences, chat with researchers across a wide range of developmental biology disciplines, keep an eye on their websites, analyse research trends across primary research articles and participate in extensive 1-1.5-hour long commissioning meetings.
Once we have agreed on a topic and a suitable author, we invite them to write for us. If they accept our invitation, the author will then often involve their students and collaborators as co-authors, and at that point we discuss the potential scope and type of the article. Of course, we also have a thorough in-house pipeline that monitors the status of all articles from invitation through to acceptance.
When we’re in the office, Alex, Ingrid, Andrea (Community Manager of the Node) and I often chat about various aspects of the job throughout the day – both formally and informally – because our work requires teamwork and collaboration. So, Ingrid and I will often discuss scheduling to make sure our publication pipeline stays tight (i.e. that every Issue publishes a few front-section content). If we have just returned from a conference, we chat with Alex and Andrea about emerging research trends and potential blogs/ posts for the community site. We also bounce around ideas for commissioning topics and share feedback on each other’s pitches, amidst a healthy dose of random life chats.
For me, the day usually ends with a quick catch-up on plans for the next day. This is also when I respond to any remaining email replies from the morning. I usually like to do a final run-through of my to-do list, ticking things off and marking any pending tasks (if there are any). And with that, I sign off for the day!
PS: Ingrid has also written a piece on a day in the life of a Reviews Editor – so do give that a read as well!
(9 votes)Loading...
Posted by Ingrid Tsang, on 14 May 2026
It’s been just over 8 months since I finished my PhD and posted my introduction as Development’s newest Reviews Editor on the Node. In this time, a constant question I’ve been asked by the ECRs around me from both my past life in academia and my current life at conferences has been “What do you do now? What does your day look like?”.
Of course, it’s not just me. Saanjbati – my partner in crime on the Reviews Editors team – has also been fielding these questions since she started this job as well. So, given the appetite from ECRs in hearing about our jobs, we’re lifting the lid on the elusive title of ‘Reviews Editor’ to show you what really goes on behind the scenes to deliver Development’s review articles and other front section content. To kick things off, Saanjbati has an article on “What does a Reviews Editor do?” and I am providing a run-down here of one sunny (!) day in April 2026, randomly chosen by my prettiest d20 die for your perusal.
It’s probably worth noting here that, as with most jobs, each day in the journal’s office is very different to the next. So do let me know if you would like to see another day in my life. But for now, hope you enjoy reading about this one!
Whilst I am writing about my experiences as a Reviews Editor at Development, all views here are my own and do not represent the journal.
——
Cambridge, England – 2026
One of April’s many Mondays.
10:00 – Get to work, catch up with the office, grab a coffee. Our core office hours are 10am till 2pm so, as a night owl, I take full advantage of this and start at 10.
10:05 – Check emails that have come in through the weekend, as well as the various reports and notification we automatically receive from our online submissions system. An author who I am really excited about has agreed to write a review for us – whoop! I respond immediately and get stuck into clearing my inbox, which seems to be perennially full no matter how much I try to empty it.
10:30 – Soreen* break! Have a quick chat with the lovely preLights Community Manager, Reinier, about possible exciting preprints to highlight between bites of sticky sugary goodness. I promise to also upload the preprints list I collated at BSDB a few weeks ago. But for now, back to emails.
11:30 – Just received a message from Saanjbati about moving an article around between scheduled issues, so we have a quick chat about this. Then back to working through my inbox.
12:30 – Done with emails! Whew. A few commissioning emails have been sent out, feedback on synopsis given, reviewers chased, submission deadlines updated. Deep dives into synthetic biology and photoreceptors surfaced from. Just a little bit more admin to go…
12:45 – … and we’re done! Time for lunch outside in some suprisingly good weather.
13:15 – After a little bit of sun (and a touch of wind), it’s back to the desk for me. This afternoon, I have a slightly overdue meeting report to send round. It’s been delayed because I lost all the notes I’d been taking on it when my computer decided to restart itself whilst I was at the conference dinner and disco. Obviously a massive shame, but it also pushes me to ruminate harder over my notes in an attempt to rescue them, which might lead me to find other ideas…? Or at least that’s what I tell myself.
13:30 – I’ve realised I need to book my hotel for a trip later this year, which I’ve already forgotten to do four times. I get this out of the way first before I forget a fifth. Makes me excited for EuroEvoDevo in Glasgow!
14:30 – Somehow got sidetracked into looking up biorxiv references made during BSDB, which prompted another deep dive into recent preprints published under ‘Developmental Biology’. Spend a few minutes in awe of how quickly research is moving in certain directions and the seemingly masses of interest in biophysical/quantitative biology. Send some ramblings to Reinier and feel mildly envious of his job.
14:40 – Back to work on my core responsibilities! I’m only halfway through thinking about the meeting report and doing follow-ups on it. But it’s already time to look through the list of articles that were accepted in the past week and think about which should be highlighted.
14:58 – Done, just in time for the research highlight (RH) meeting! This is our weekly meeting where we discuss all the back section (i.e. primary research) articles and decide which to highlight. There are so many interesting papers this week, it’ll be quite hard to choose and I’m excited for the discussion.
15:35 – RHs have been picked, and I’m back at my desk to do a final read-through of the paper I’ve been assigned, just to make sure it’s as interesting as it seemed from my initial read-through.
15:40 – An email from our production team has just come through about a review article I’ve handled. Spend 10 minutes on this. Then another message comes through regarding some travel admin. Another 10 minutes gone.
16:00 – Back to reading this week’s RH paper. I personally really like it and am even more excited to write the highlight, although some of it is feeling quite anatomically complicated and will be difficult to describe in just 200 words without an illustration… Ohh well, that’s a problem for the future.
16:15 – OK, the various miscellaneous items that came in are done. Time to really lock-in on the meeting report, which needs to be sent today. It’s a nice creative exercise to reflect on all the science discussed at the meeting, but quite stressful to go through the whole programme and all my notes and synthesise something coherent for the rest of the team when under a time pressure.
16:50 – My brain is fried, my fingers feel like they’re about to fall off and my spirits are in dire need of chocolate. But the meeting report has finally been sent off! Time to wrap up a few things. As always, some important emails trickle through right as I’m about to leave. I resolve to address them on my way home.
17:00 – I leave early on Mondays so rush out for my bus. Bye!
*(other brands of malt loaves exist etc. etc.)
——
Did you know that anyone can publish on the Node? If you’ve been inspired to write a piece for the developmental biology community, feel free to register an account and then make your own blog post here: https://thenode.biologists.com/wp-admin/post-new.php
(3 votes)Loading...
Posted by Reinier Prosee, on 13 May 2026
preLighters with expertise across developmental and stem cell biology nominate a few recent developmental and stem cell biology (and related) preprints they’re excited about and explain in a few paragraph why. Concise preprint highlights, prepared by the preLighter community – a quick way to spot upcoming trends, new methods and fresh ideas.
Want to join us at preLights? If you’re keen to gain some science writing experience and be part of a friendly, diverse and international community, consider joining preLights and writing a preprint highlight article.
Preprint:
Preprint:
Canonical mTOR signaling supports complete fin regeneration
Josane F. de Sousa, Gabriela Lima, Louise Perez, Michaela Tsanova, Cyrus Bronson, Garrison Boehl, Icyss Sargeant, Rogerio Gomes, Aline C. Dragalzew, Wainna B. Mendes, Igor Schneider
preLight:
Fins, and cells, and signals, and regeneration, oh my! How the Senegal bichir regrows its fins after amputation.
The authors of this preprint investigate fin regeneration in the Senegal bichir (Polypterus senegalus), a type of ray-finned fish capable of full fin regeneration; this biological characteristic is quite impressive on its own, as the fin includes different tissues, such as skeletal, cartilaginous, muscular and connective tissue with complexity comparable to that found in tetrapod limbs.
The preprint authors show that regeneration entails the activation of canonical mTOR cellular programs, as treatment with the mTOR inhibitor rapamycin prevented this regeneration, though wound healing proceeded normally. Signaling was activated upon amputation, first in epithelial cells in the epidermis and then in adjacent mesenchymal cells below the superficial layers, as well as myeloid cell types.
It seems that mTOR programs in myeloid populations are responsible for the coordination of regenerative procedures across different cell types, as well as its eventual resolution. Moreover, existence of such programs in species of fish highlights the ‘ancient’ evolutionary origins of tissue regeneration, giving hope for application of these principles in other species.
Preprint:
Whole-Cell Proteomics Identifies Novel Regulators of Ciliogenesis Beyond the Axoneme
Xiaolu Xu, Yanbao Yu, Tony Zheng, Fiona Clark, Jean Ross, Neha Sindhu, Andre L P Tavares, John B Wallingford, Shuo Wei, Jian Sun
preLight:
Uncovering new players in ciliogenesis by whole-cell proteomics
Motile cilia are microtubule-based organelles that are involved in fundamental biological processes such as embryonic development, signalling, and mucus clearance. Their dysfunction results in several disorders known as ciliopathies.
Several efforts over the years have helped in elucidating the molecular architecture of motile cilia and in understanding ciliary structures and functions. Moreover, previous proteomic studies provided valuable insights into the axonemal composition. However, many molecular regulators of ciliogenesis remain unknown and other critical cellular components beyond the axoneme involved in ciliogenesis require further investigation.
In this preprint, the authors performed a high-resolution whole-cell proteomic profile of multiciliated cells (MCC), whose function is regulated by axonemal proteins, basal bodies, cytoplasmic factors, and nuclear components. They induced MCC cell fate in Xenopus, therefore enriching ciliary proteins and generating mucociliary organoids. Following their high-depth proteomic profiling, they identified several previously uncharacterized proteins that are essential for MCC maintenance and ciliogenesis. Through in situ hybridization, immunostaining, and gene knockdown, they further confirmed the new candidates, thus providing new potential targets to be further explored to gain a better understanding of the mechanisms related to ciliopathies.
Preprint:
Synthetic lumen rounding directs neural progenitor division mode
Marina Marchenko, Guillermo Martínez Ara, Juslina Pulikkal, Keisuke Ishihara, Miki Ebisuya
preLight:
Cells read lumen geometry to instruct division mode and lineage progression
During early brain development, tissue geometry – including lumen geometry – dynamically changes; a process which varies across species. But does this geometry simply result from development, or does it actively instruct how cells behave?
The authors of this preprint investigate this question by artificially controlling lumen geometry in brain organoids using two approaches: chemical induction of Shroom3, a protein that drives apical constriction and OptoShroom3, an optogenetic system enabling precise, light-controlled activation. The latter enables spatially targeted control without affecting overall Shroom3 levels within the organoids.
The results reveal that lumen geometry is not a passive consequence of development, but an active regulator of cell behavior. Chemically-induced Shroom3 organoids formed much rounder lumens and neural buds, and generated basal progenitor cells faster than controls, while cells gradually switched from vertical to horizontal cleavage planes over time, a critical reorientation since horizontal division results in asymmetric cell division that generates more basal progenitors, whereas vertical division (in controls) maintains more apical progenitors. When the authors used OptoShroom3 to create rounded lumens with localized blue light illumination, apical progenitor cells in target buds similarly shifted toward horizontal cleavage planes within an hour, whereas those without illumination (control bud within the same organoid) did not.
These findings demonstrate that cells ‘read’ their geometric environment to make developmental decisions, suggesting lumen shape as a key determinant, not merely a consequence of morphogenetic outcomes, a principle likely applicable broadly across organs and species.
Preprint:
Lamin A/C directs nucleosome-scale chromatin remodeling to define early lineage segregation in mammals
Alice Sherrard, Liangwen Zhong, Caroline Hoppe, Srikar Krishna, Scott Youlten, Curtis W. Boswell, Stephen Cross, Fiona E. Sievers, Goli Ardestani, Denny Sakkas, Liyun Miao, Zachary D. Smith, Berna Sozen, Antonio J. Giraldez
preLight:
Nuclear lamins direct the first lineage decision in mammalian cells
The first lineage decision during mammalian development into the inner cell mass (ICM) and trophectoderm (TE) is well known to be initiated by transcriptional and epigenetic factors and reinforced by mechanical forces. While global chromatin organization is understood to be important for this process, it remains unclear how the fine-scale distribution of chromatin and nucleosomes plays a role in these cell fate decisions.
To investigate this, the authors set up an improved chromatin electron tomography protocol called ChromEMT to observe nanometer-scale sub-nucleosomal structures. Using ChromEMT on human and mouse cell cultures before, during, and after specification into ICM and TE, they identified key differences in chromatin packing density and nucleosome spacing between these lineages. Importantly, they found that TE nuclei have highly compacted chromatin at their nuclear periphery. In line with this increased peripheral compaction, the authors could show that proteins located at the inner nuclear membrane, particularly lamins A and C, are specifically upregulated in TE cells across mammals. Loss of Lamin A/C resulted in loss of peripheral chromatin compaction and upregulation of pluripotency genes in TE cells, suggesting an overall transition to ICM-like characteristics. This, in turn, impairs normal progression through embryogenesis.
In concert with many more supporting findings, this preprint demonstrates how chromatin compaction and nuclear lamins directly shape early mammalian development.
Preprint:
Abnormal ventricular wall patterning precedes and drives MYBPC3 hypertrophic cardiomyopathy
Alejandro Salguero-Jiménez, Alba Pau-Navalón, Marcos Siguero-Álvarez, Carlos Relaño-Rupérez, Javier Santos-Cantador, María Sabater-Molina, Xiaoxi Luo, Laura Lalaguna, Laura Sen-Martín, Daniel Martín Pérez, Abel Galicia Martín, Bin Zhou, Juan Antonio Bernal Rodríguez, Fátima Sánchez-Cabo, Enrique Lara-Pezzi, Jorge Alegre-Cebollada, Juan R. Gimeno-Blanes, Donal MacGrogan, José Luis de la Pompa
preLight:
More ‘heart’, more problems; a natural history of myocardial hypertrophy progression from embryonic development to adulthood and the role of sarcomeric protein mutations (Mybpc3) in its emergence.
The authors of this preprint investigated the developmental biology underlying hypertrophic cardiomyopathy and left ventricular non-compaction in mice. To this end, they used CRISPR-Cas9, a method used to induce genetic alterations, to introduce MYBPC3 frameshift mutations in the mouse genome and then followed these mice from embryonic and fetal development into adulthood. Adult mice with these mutations displayed hypertrophic cardiomyopathy but with no evidence of left ventricular non-compaction, as opposed to humans. These formations began as trabecular enlargement and crypt enlargement during embryonic development and progressed to hypertrophy in adulthood. Lineage tracing studies further showed invasion of cardiomyocytes normally found in compact myocardium (Hey+ cardiomyocytes), into the developing trabeculae, while after birth, Hey+ cardiomyocytes became restricted to compact myocardium and the inner trabecular myocardium underwent hypertrophy. This is associated with downregulation of the Prdm16; this study highlights how the latter has potential to combat myocardial hypertrophy.
This study highlights the natural history of myocardial hypertrophy and how loss of Mybpc3 is associated with reduction in Prdm16 and onset of pathological hypertrophic remodeling.
(No Ratings Yet)Loading...
Posted by Debora Bogani, on 12 May 2026
The Medical Research Council provided £750K in funding for the National Mouse Genetics Network’s Business Engagement Fund with a call for applications in early 2023. The Business Engagement Fund supported 3–12-month projects, providing grants of £15–100K, with the expectation that matched funding would be provided by industry collaborators. Funded projects were designed to build and strengthen collaborations between the Network and businesses through feasibility, pilot, or initial studies. These activities aimed to explore ideas and generate initial data to support the development of competitive collaborative grant proposals.
We are now reporting on the first of these projects, highlighting how collaborative endeavours of this kind can help shape preclinical research and accelerate the development of therapeutic interventions.
The project was a partnership between Professor Nick Greene of University College London and OutFox Bio. Nick is a member of the Congenital Anomalies Cluster and a leading academic researcher studying a range of birth defects, with a long-standing interest in the role of folates in development and inherited metabolic disease. OutFox Bio is a delivery technology company focused on the development and optimisation of next-generation lipid nanoparticle (LNP) gene delivery technologies, designed to enable new gene therapy approaches and expand their potential applications.
Non-Ketotic Hyperglycinemia (NKH) is a life-limiting autosomal recessive neurometabolic disease that presents in neonates with lethargy, hypotonia, myoclonic jerks and apnoea. Affected children experience profound neurological impairment and complex epilepsy. Around one-third of infants with severe neonatal-onset NKH die within the first year, but age at death is highly variable, with some children surviving into their teenage years.
NKH is caused by mutations in genes that encode the glycine cleavage system (GCS). Most patients (80%) carry mutations in GLDC (glycine decarboxylase), with the remainder carrying mutations in AMT (aminomethyltransferase). The GCS decarboxylates glycine, with the concomitant transfer of a one-carbon (1C) group to tetrahydrofolate (THF), generating methylene-THF. Subsequent reactions in folate one-carbon metabolism (FOCM) provide 1C groups for multiple outputs, including nucleotide biosynthesis and methylation reactions. Hence, GCS dysfunction leads both to the accumulation of excess glycine in the body and to suppression of FOCM.
There is no cure for NKH; current treatments have limited efficacy. Prognosis remains very poor, highlighting an urgent unmet need for novel therapies. There is currently no established standard of care for NKH, although patients are typically treated with multiple anti-seizure medications. The most common treatment is sodium benzoate, which is administered to lower circulating glycine by stimulating glycine conjugation in the liver, generating hippurate (benzoylglycine) for excretion. Benzoate helps with seizure control but can be toxic and is associated with severe gastrointestinal side effects, necessitating long-term co-administration of proton-pump inhibitors which may carry additional risks. Replacement of benzoate has been highlighted as a priority during discussions with families of affected children.
To investigate NKH pathogenesis and develop novel treatments, Nick’s group developed a GLDC-deficient mouse model that recapitulates hallmark features of the disease, including elevated plasma and tissue glycine and neurological abnormalities. Loss of glycine cleavage system activity was confirmed by enzymatic assay and metabolic tracing using isotopically labelled glycine. Glycine is both a biomarker and a therapeutic target in NKH; both glycine and guanidinoacetate, a glycine–arginine conjugate, are epileptogenic.
In GLDC-deficient mice, the group observed that liver-specific reinstatement of GLDC expression or stimulation of hepatic glycine conjugation through benzoate administration led to normalisation of liver tissue glycine and glycine derivatives, correction of blood glycine concentrations, and reduction of glycine levels in the brain, the main site of NKH pathogenesis. These studies provide proof of principle for liver-directed therapy as a means of controlling systemic and brain glycine levels.
The causative genes are known, making NKH potentially amenable to therapies that restore gene expression. The aim is to develop RNA-based approaches to reinstate GLDC expression and normalise metabolism in NKH. Lipid nanoparticle (LNP)-mediated delivery of mRNA to the liver represents an attractive methodology for therapeutic gene expression. LNP systems have proven to be effective and safe for mRNA delivery and are already in clinical use for other conditions.
In this NMGN Business Engagement Fund project, undertaken in partnership with OutFox Bio, the team initially sought to address two key questions using a reporter-encoding mRNA. First, they tested whether the liver in NKH remains amenable to LNP-mediated mRNA delivery despite abnormal metabolism. Second, they sought to identify the optimal LNP composition for mRNA delivery to the liver in the NKH GLDC-deficient mouse model. The team identified LNP compositions with improved efficacy compared with clinically approved benchmarks. They also confirmed that compromised glycine metabolism in the liver does not hinder uptake or expression of LNP-delivered mRNA in the NKH mouse model. For example, expression of LNP-mediated reporter expression was at least as high in GLDC-deficient mice as in wild-type mice following treatment with each LNP composition. These findings provided the proof of concept for extending the project to therapeutic mRNA, prioritising the lead LNPs.
The ongoing objective of the project is to develop an mRNA-based therapy that reinstates liver GLDC expression, normalises metabolism, and improves neurological outcomes in the GLDC-deficient NKH mouse model. Outputs from this project are expected to provide an evidence base for advancing this approach towards clinical trials in children with NKH.
Nick presented some of this work at the NKH Crusaders 11th Annual International Family Conference in Boston, where he gave a presentation and took part in several round-table discussions. The event was reported on social media, where Nick’s talk was also mentioned.
(No Ratings Yet)Loading...
Posted by Michel Milinkovitch, on 9 May 2026
Sir David Attenborough turned 100 yesterday!
Sure, we do what we do for the maths, physics and molecular biology underlying development and evolution … but also out of fascination for the beauty and complexity of Life.
So, we decided to produce a 3.5-minute movie in which an extraordinary guest celebrates Attenborough’s birthday.
See for yourself: https://youtu.be/oAwsMkMdAMA
We hope that our movie will contribute to honouring the man who helped the world fall in love with nature.
Social media links:
-X/Twitter: https://x.com/LANEVOL/status/2052621779261124672?s=20
-Bluesky: https://bsky.app/profile/lanevol.bsky.social/post/3mlcysxxa3s25
-LinkedIn: https://www.linkedin.com/
Have a great Attenborough weekend !
Michel & Athanasia
https://www.lanevol.org/news/article/extraordinary-guest-celebrate-sir-david-attenborough
https://www.lanevol.org
(1 votes)Loading...
Posted by Andrea Murillo, on 4 May 2026
Date: 6-9 December 2026
Location: Buxted Park, East Sussex, UK
Organisers: Elena Casacuberta and James Gahan
One of the central questions in developmental biology is how different cell fates are generated from a single founding cell. Although great strides have been made in our understanding of this problem in animals, the evolutionary origins of this process are not understood. It is known that many unicellular organisms progress through different cell stages during their life cycle, known as temporal cell differentiation, and it has been hypothesized that spatial cell differentiation (as seen in animals) evolved from this more ancient differentiation-mode. A full understanding of how this occurred has been hampered by a lack of information on the basic principles underlying temporal cell differentiation in the closest relatives of animals, the unicellular holozoans.
In recent years, several studies have revealed that many of the genes and pathways directly related to development and cell fate in animals were already present in their unicellular ancestors. Moreover, many examples have shown the formation of specialized cell types in response to specific environmental ques and transient multicellular structures have been reported in many unicellular holozoan lineages. Therefore, recent discoveries strongly point towards an earlier origin of several developmental processes, including cell differentiation, than was previously thought and make a strong case that understanding the mechanisms underpinning “development” in these unicellular lineages will be key to understand the emergence of definitive animal cell differentiation and development.
The Workshop will consist of sessions of talks and discussions centred around various aspects of development to unicellular holozoans. Each session will contain a mixture of researchers working on unicellular holozoans and those working on other eukaryotic systems who will provide alternative insights. Through these sessions the Workshop will build knowledge aiming to produce a white-paper document outlining the emerging conceptual framework in the field, the major outstanding questions as well as seeding collaborative efforts to address these questions.
Elena Casacuberta Institute for Evolutionary Biology, Spain
James Gahan University of Galway, Ireland
Detlev Arendt EMBL, Germany
David Booth University of California, San Francisco, USA
Thibaut Brunet Institut Pasteur, France
Pawel Burkhardt University of Bergen, Norway
Susana Coelho Max Planck Institute for Biology Tübingen, Germany
Omaya Dudin University of Geneva, Switzerland
Nicole King University of California, Berkeley, USA
Lucie Laplane CNRS, Université Paris, France
Eric Libby Umeå University, Sweden
Aurora Mihaela Nedelcu University of New Brunswick, Canada
Àlex de Mendoza Queen Mary University of London, United Kingdom
Iñaki Ruiz-Trillo The Institute of Evolutionary Biology, Spain
Florentine Rutaganira Stanford University, USA
Arnau Sebé-Padrós Centre for Genomic Regulation, Spain
Hiroshi Suga Prefectural University of Hiroshima, Japan
Katrina Velle UMass Dartford, USA
Renske Vroomans University of Cambridge, United Kingdom
We offer 10 funded places for early-career researchers (PhD, postdocs and PIs in the first three years of their first appointment) to attend our Workshops along with the 20 invited speakers. We just ask that you pay for your own travel costs. If you would like to attend please complete the online application form and include a one page CV and a letter of support from your supervisor. If your supervisor would prefer to send the letter directly to us please ask them to email it to workshops@biologists.com
All attendees are expected to actively contribute to the Workshops by asking questions at presentation sessions and taking part in discussions, as well as giving a short talk on their research.
The early-career research deadline is on Friday 12 June 2026. For more information, visit the Company’s Workshops page.
(No Ratings Yet)Loading...
Posted by Prashant Tewari, on 30 April 2026
This meeting was particularly meaningful to me, as it marked my first engagement with the developmental biology community in India since beginning my academic training abroad four years ago in 2021. I joined the laboratory of Smadar Ben-Tabou de-Leon at the University of Haifa, Israel, for my master’s research and subsequently continued in the same group for my doctoral studies. My research focuses on the regulation of sea urchin larval skeletogenesis, with a particular emphasis on the role of cytoskeletal remodelling proteins in controlling morphogenesis. Against this backdrop, the meeting provided a valuable opportunity for me to reconnect with the broader research community and situate my work within the expanding landscape of developmental biology.
The conference brought together a diverse group of established and early-career scientists, including principal investigators, graduate students, and postdoctoral researchers from across India and internationally. It highlighted the rapidly evolving nature of the field, where classical embryology is increasingly integrated with stem cell-based models, quantitative approaches, and systems-level perspectives. Personally, one of the best parts of this conference was that there were no parallel sessions – so, we didn’t have to choose between different talks (or seminar halls!).
One of my favourite talks was by Alfonso Martínez Arias (Universitat Pompeu Fabra, Spain), a renowned developmental biologist and one of the authors of the exceptional book: Wolpert’s Principles of Development (Wolpert’s Principles of Development – Paperback – Lewis Wolpert; Cheryll Tickle; Alfonso Martinez Arias; Marysia Placzek – Oxford University Press). He presented the gastrulation from the perspective of pluripotent stem cells and gastruloids, highlighting how self-organizing stem cells aggregate when exposed to defined signalling and can generate post-gastrulation-like body plans.
Extending the gastruloid paradigm to human biology, Maneesha Inamdar (Institute for Stem Cell Science and Regenerative Medicine, India) presented a robust, accessible human gastruloid-based platform for studying early cell fate decisions and teratogenicity. Metabolism plays an instructive role during early development – was the major takeaway from Maneesha’s talk. Her work addressed a longstanding challenge in developmental biology and medicine: the lack of ethically permissible and human-relevant models for post-implantation development. Towards the end of her talk, she also introduced the Centre for Research, Application and Training in Embryology (CReATE) – a research institute within theInStem, that aims to conduct innovative research to advance understanding of early human development.
The discussion on the role of metabolism in development was continued by Sally Dunwoodie (Victor Chang Cardiac Research Institute, Australia), who focused on the role of nicotinamide adenine dinucleotide (NAD) metabolism in embryogenesis. She presented that during early development, NAD deficiency can lead to a plethora of congenital abnormalities, since metabolism is a key regulatory layer in embryogenesis.
The meeting also included a dedicated session on the themes of organogenesis and regeneration across organisms and developmental systems. Peter Currie (Monash University, Australia) discussed comparative insights into muscle stem cell systems across vertebrates, highlighting how distinct stem cell populations are regulated during growth, maintenance, and regeneration. James Briscoe (Francis Crick Institute, UK) gave the Jean Brachet Memorial Lecture, highlighting the importance of temporal dynamics and spatial patterning during spinal cord development. His talk emphasised how cells can interpret morphogen signals in a time-dependent fashion to precise neuronal identities. He famously presents the “6 Ps of Developmental Biology”—position, pattern, proportions, precision, pace, and purpose. Adding on to this theme, Raj Ladher (National Centre of Biological Sciences, India) presented findings on cochlear morphogenesis, showcasing how tightly regulated cell differentiation and tissue remodelling generate the complex architecture of the inner ear. Complementing these studies on organ morphogenesis, Richard Behringer (MD Anderson Cancer Centre, USA) talked about tissue remodelling during sex differentiation, highlighting how anti-Müllerian hormone–dependent epithelial-mesenchymal interactions drive Müllerian duct regression during male development.
Several talks highlighted the emerging importance of mechano-genetic regulation of the developmental program. Speakers Tamal Das (Tata Institute of Fundamental Research, India) and Priti Agarwal (National Centre of Biological Sciences, India) discussed how cytoskeletal dynamics, actomyosin contractility, and mechanical feedback influence cell behaviour and organ morphogenesis. Their work demonstrated that morphogenesis commences from a close interaction between biochemical signalling and physical constraints. On par with this perspective, Shankar Shrinivas’s (University of Oxford, UK) work demonstrated patterned heterogeneities in tissue mechanics during early mammalian development, showing how spatial differences in mechanical properties guide cell migration and anterior patterning. All together, these talks emphasized the importance of mechanical forces’ role as an active regulatory layer across different developmental scales. Richa Rikhy (Indian Institute for Sciences, Education and Research, India) delivered the Anne McLaren Award Lecture. Her work using Drosophila as a model system emphasized that mitochondria are not merely metabolic organelles but function as active regulators of developmental processes. She highlighted how mitochondrial morphology—regulated by coordinated fission and fusion events—modulates cellular metabolism, redox state, and signalling pathways, ultimately influencing cell fate decisions.
Bringing a developmental disease perspective, Loydie Majewska (McGill University Health Centre Research Institute, Canada) showed that TMED2-dependent protein trafficking is essential for craniofacial and heart morphogenesis. Using conditional mouse models, she linked defects in secretory pathway function to congenital malformations, underscoring how embryological mechanisms inform human disease. Extending the translational scope beyondcongenital disorders, Tina Mukherjee (Institute for Stem Cell Science and Regenerative Medicine, India) discussed how developmental programs governing sensory perception shape mosquito vector competence and disease transmission. She presented how developmental programs, which govern sensory systems, shape host-seeking behaviour and disease transmission. An intellectually stimulating talk came from Kavita Babu (Centre for Neuroscience, Indian Institute of Life Sciences, India), who demonstrated that long-term associative memory in Caenorhabditis elegans can be transmitted between individuals via extracellular vesicles. Her work extended the concept of biological information transfer beyond genetic inheritance and intracellular memory.
In addition to the scientific sessions, the Society for Developmental Biology (SDB) recognised the historical contributions of Padmanabhan Babu and honoured him with the society’s inaugural Campus Award. The Campus Award, as described by Richard Behringer (MD Anderson Cancer Center), recognizes research discoveries that serve as guiding milestones for the field and have paved the way for major conceptual breakthroughs. Babu’s early work in C. elegans genetic screens led to the isolation of the e912 mutant, an allele foundational to the discovery of the first microRNA. This mutation, obtained by Babu during his post-doctoral research in Sydney Brenner’s laboratory in the early 1970s, later enabled pivotal studies that revealed the role of lin-4 in post-transcriptional regulation, a discovery honoured by the 2024 Nobel Prize in Physiology or Medicine for microRNA research. The SDB highlighted his work as a landmark contribution that helped shape the modern field of developmental biology and inform subsequent research on gene regulatory mechanisms (Society for Developmental Biology | Resource).
Altogether, the 2025 Joint Meeting of InSDB and ISD was a great success in bringing together researchers across the globe with expertise in classical embryology, stem-cell models, metabolic regulation, organelle dynamics, mechanical control and regenerative biology. The final day of the conference concluded with a gala dinner at the beautiful Mayfair Resort, Orissa, India, on the coast of the Bay of Bengal. The evening culminated in an impromptu dance session by many attendees, which beautifully captured the vibrant and diverse cultural spirit of India.
(1 votes)Loading...
